Poor Efficacy of Immune Checkpoint Inhibitors Plus Chemotherapy in Lung Cancer Patients with EGFR/ERBB2 Exon 20 Insertion

Background: EGFR and ERBB2 exon 20 insertion (Ex20ins) account for a small fraction of patients with EGFR mutations. The efficacy of immune checkpoint inhibitors (ICIs) for these patients was still controversial. Methods: This retrospective study enrolled lung cancer patients harboring either EGFR o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yue, Fu, Yang, Chen, Yueyun, Li, Qing, Liu, Ting, Ding, Zhenyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670615/
https://www.ncbi.nlm.nih.gov/pubmed/37999141
http://dx.doi.org/10.3390/curroncol30110721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670615/
https://www.ncbi.nlm.nih.gov/pubmed/37999141
http://dx.doi.org/10.3390/curroncol30110721

Ejemplares similares